Jazz Pharmaceuticals (JAZZ) Current Deferred Tax Assets (2012 - 2015)

Jazz Pharmaceuticals' Current Deferred Tax Assets history runs 4 years deep, the most recent figure standing at $50.0 million for Q3 2015.

• On a quarterly basis, Current Deferred Tax Assets rose 40.09% year-over-year to $50.0 million in Q3 2015; TTM through Sep 2015 was $50.0 million, a 40.09% increase from a year earlier, with the FY2014 full-year figure at $48.4 million, up 44.11% from the prior year.
• Current Deferred Tax Assets declined to $50.0 million in Q3 2015 per JAZZ's latest filing, from $50.6 million in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $50.8 million in Q1 2015 and bottomed at $33.6 million in Q4 2013.
• The 4-year median for Current Deferred Tax Assets is $46.1 million (2013), against an average of $43.0 million.
• Biggest YoY gain for Current Deferred Tax Assets was 44.11% in 2014; the steepest drop was 24.47% in 2014.
• Year by year, Current Deferred Tax Assets stood at $35.8 million in 2012, then dropped by 6.14% to $33.6 million in 2013, then soared by 44.11% to $48.4 million in 2014, then grew by 3.23% to $50.0 million in 2015.
• Per Business Quant, the three latest JAZZ Current Deferred Tax Assets figures stand at $50.0 million (Q3 2015), $50.6 million (Q2 2015), and $50.8 million (Q1 2015).